Bottom Line: The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended ...
The role of high-risk human papillomavirus (hrHPV) testing in primary cervical screening has not been established. We generated a randomised evaluation design ultimately to clarify whether primary ...
The use of human papillomavirus (HPV) DNA testing as an initial screening step followed by triage with a standard Pap test (cytology) and repeat HPV DNA testing may increase the accuracy of cervical ...
Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...
Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...
January 21, 2010 — For women 35 years of age or older, human papillomavirus (HPV)-based screening is more effective in detecting high-grade lesions and preventing invasive cervical cancer than ...
October 28, 2009 — A large randomized study has found that, compared with the conventional Papanicolaou (Pap) test, liquid-based cytology is not more sensitive or specific in detecting precancerous ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women ages 24 to ...
Please provide your email address to receive an email when new articles are posted on . Women screened for cervical cancer via primary HPV testing had a lower likelihood of developing grade 3 cervical ...
Bottom Line: The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended ...
We included 717 cancers from 23 studies. The pooled sensitivity of cytology to cancer at a cutoff of a high-grade squamous intraepithelial lesion (HSIL) or worse was 79.4% (95% CI, 67.7% to 86.0%).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results